New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Trius Therapeutics (TSRX)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Income Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
31-MAR
2012
30-JUN
2012
30-SEP
2012
31-DEC
2012
31-MAR
2013
Total Revenue
9.83M
6.22M
5.97M
5.16M
1.73M
Cost of Revenue
-369K
0
0
0
0
Gross Profit
10.2M
6.22M
5.97M
5.16M
1.73M
Research & Development
16.8M
16.4M
19.3M
16.5M
12.5M
SG&A
3.00M
3.31M
4.43M
4.65M
4.50M
Amortization & Deprec
369K
419K
0
0
293K
Other Expenses
0
-426K
-13.0K
-13.0K
-304K
Total Operating Expenses
20.2M
19.7M
23.7M
21.1M
17.0M
Operating Income
-10.0M
-13.5M
-17.8M
-15.9M
-15.3M
Other Income
2.41M
-955K
91.0K
1.72M
-1.97M
EBIT
-7.60M
-14.4M
-17.7M
-14.2M
-17.3M
Minority Interest
0
0
0
0
0
Interest Expense
0
0
0
0
0
Income Before Taxes
-7.60M
-14.4M
-17.7M
-14.2M
-17.3M
Income Taxes
0
0
0
0
0
Net Income from Continuing Ops
-7.60M
-14.4M
-17.7M
-14.2M
-17.3M
Income - Discontinued Ops
0
0
0
0
0
Extraordinary Items
0
0
0
0
0
Effect of Accounting Changes
0
0
0
0
0
Other Items
0
0
0
0
0
Net Income
-7.60M
-14.4M
-17.7M
-14.2M
-17.3M
Preferred Dividends
0
0
0
0
0
Net Income to Common
-7.60M
-14.4M
-17.7M
-14.2M
-17.3M
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour